(BENGALURU), Nov 6 (Reuters) - India's Max Healthcare Institute MAXE.NS on Monday reported a 38%
rise in its second-quarter profit before tax, as it earned more revenue per bed.
The hospital and diagnostic services provider's consolidated profit before tax for the quarter ended
Sept. 30 stood at 3.66 billion rupees ($43.99 million) compared with 2.65 billion rupees a year ago.
Max Healthcare's average revenue per occupied bed (ARPOB) was 74,600 rupees in the second-quarter, up
13% year-on-year.
For further results highlights, click: (Full story)
KEY CONTEXT
Max Healthcare is the first to report the September-quarter results among its peer hospital chains,
with Fortis Healthcare FOHE.NS , Apollo Hospitals Enterprise APLH.NS and Aster DM Healthcare ATRD.NS
due to announce results in the coming days this week.
Analysts had expected higher occupancy and growth in average revenue per occupied bed for Max
Healthcare. The improvement in these operating parameters would also help towards capital allocation for
bed capacity expansion, per analysts.
PEER COMPARISON
Valuation (next Estimates (next 12 Analysts' sentiment
12 months) months)
RIC PE EV/EBITD Revenue Profit Mean # of Stock to
A growth growth rating* analysts price
target**
Max Healthcare MAXE.NS 41.05 27.41 25.33 14.03 Buy 14 0.94
Institute Ltd
Fortis Healthcare FOHE.NS 34.04 18.55 11.51 24.31 Buy 12 0.87
Ltd
Apollo Hospitals APLH.NS 53.62 26.22 16.91 39.16 Buy 21 0.93
Enterprise Ltd
Aster DM Healthcare ATRD.NS 24.86 10.94 11.41 71.93 Buy 6 1.06
Ltd
* Mean of analysts' ratings standardised to a scale of Strong Buy, Buy, Hold, Sell, and Strong Sell
** Ratio of the stock's last close to analysts' mean price target; a ratio above 1 means the stock is
trading above the PT
JULY-SEPT STOCK PERFORMANCE
-- All data from LSEG
-- $1 = 83.1927 Indian rupees
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
JULY-SEPT STOCK PERFORMANCE https://tmsnrt.rs/3Qs8QWp
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
(Reporting by Anisha Ajith in Bengaluru)
((anisha.ajith@thomsonreuters.com;))